Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

X4 Pharmaceuticals (XFOR) Non Operating Income (2018 - 2025)

Historic Non Operating Income for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to -$2.3 million.

  • X4 Pharmaceuticals' Non Operating Income fell 710.68% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 6708.7%. This contributed to the annual value of -$739000.0 for FY2024, which is 11148.76% down from last year.
  • Per X4 Pharmaceuticals' latest filing, its Non Operating Income stood at -$2.3 million for Q3 2025, which was down 710.68% from -$547000.0 recorded in Q2 2025.
  • X4 Pharmaceuticals' 5-year Non Operating Income high stood at $24.9 million for Q3 2023, and its period low was -$29.9 million during Q2 2023.
  • Over the past 5 years, X4 Pharmaceuticals' median Non Operating Income value was -$734000.0 (recorded in 2021), while the average stood at $143000.0.
  • Within the past 5 years, the most significant YoY rise in X4 Pharmaceuticals' Non Operating Income was 182560.55% (2023), while the steepest drop was 458526.65% (2023).
  • Quarter analysis of 5 years shows X4 Pharmaceuticals' Non Operating Income stood at -$1.1 million in 2021, then crashed by 205.74% to -$3.5 million in 2022, then soared by 273.38% to $6.1 million in 2023, then tumbled by 163.18% to -$3.8 million in 2024, then surged by 39.29% to -$2.3 million in 2025.
  • Its Non Operating Income was -$2.3 million in Q3 2025, compared to -$547000.0 in Q2 2025 and $9.8 million in Q1 2025.